Hu et al. [14] found that miR-128 could inhibit the occurrence and development of NSCLC by inhibiting the expression of vascular endothelial growth factor C (VEGF-C), thereby inhibiting lymphangiogenesis and angiogenesis. Here, VEGFC is linked to non-small cell lung carcinoma.